Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-15

Clinical Trial Update: A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of a topical spray B244 for people with elevated blood pressure (prehypertension and Stage I hypertension) completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • B244

Snippet

Sponsor: AOBiome LLC | Conditions: Prehypertension, Hypertension, Stage I | Phase 2 | Status: COMPLETED | Results posted: 2022-08-15